Conference Agenda
Day 1 - Tuesday, April 28, 2026
8:00-9:30am: Pre-conference Women’s Networking Breakfast. RSVP required
11:30-11:55am: Registration and box lunch — Great Room Foyer
11:55-12:00pm: Welcome/Opening — Great Room
12:00-12:30pm: Keynote: to be announced
12:30-1:00pm: Lee Fleisher, Principal and Founder, Rubrum Advising
1:05-1:45pm: Leveraging Clinical Expertise: Making the Most of KOLs in MedTech
Tommy Reid, Partner, McKinsey & Company
Adam Saltman, Chief Medical Officer, NAMSA
David Filmore, Executive Editor, Market Pathways (moderator)
1:50-1:55pm: Moderator —
1:55-2:25pm: Presenting companies
2:30-3:10pm: Commercialization Panel Breaking In: Rolling out Medtech in Europe
Tanja Dowe, Managing Director, Angelini Ventures
Bryant Grigsby, CEO, PDV MedTech
David Noonan, CTO, Moon Surgical
Donal O’Shea, CEO, Deciphex
Reed Miller, Senior Writer/Market Analyst, Medtech Strategist (moderator)
3:10-3:30pm: Networking Break —
3:30-4:25pm: MedTech Market Pathways: Policy, Evidence, and Innovation
Tonya Dowd, Executive Vice President, Reimbursement, Value Generation, and Market Access (RVMA), PRIA Healthcare
Steve Farmer, Senior Partner & Co-Owner, ABIG Health; Former Chief Strategy Officer/Coverage and Analysis Group, CMS
Josh Makower, MD, The Yock Family Professor, Professor of Medicine and of Bioengineering; Stanford University Schools of Medicine and Engineering, The Byers Family Director and Co-Founder, Stanford Mussallem Center for Biodesign
David Filmore, Executive Editor, Market Pathways (moderator)
4:30-4:40pm: Moderator —
4:40-5:30pm: Presenting companies
5:35-6:35pm: MedTech Innovator - Dublin: Host: Paul Grand, Founder & CEO, MedTech Innovator
6:35-7:45pm: Networking Reception
Day 2 - Wednesday, April 29, 2026
8:00-8:30am: Registration & Welcome Coffee — Great Room Foyer
8:30-8:35am: Moderator —
8:35-9:25am: Presenting companies
9:25-10:05am: Betting on Innovation: Early Investment in Tough Times
Barbara Castellano, Partner, Panakes Partners
Janke Dittmer, Partner, Gilde Healthcare
Thom Rasche, Partner, Earlybird
Bibi Sattar Marques, Partner, Buenavista Equity Partners
Reed Miller, Senior Writer/Market Analyst, Medtech Strategist (moderator)
10:05-10:45am: It’s Getting Mighty Crowded: Carving Out Space in Late-Stage Investing
Antoine Papiernik, Chairman & Managing Partner, Sofinnova Partners
Alexander Schmitz, Partner, Endeavour Vision
Eric Shiozaki, Venture Partner, Revelation Partners
Aneta Sottil, Partner, Andera Partners
Hal Stowe, Senior Manager, Regulatory Intelligence, Eurofins
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
10:45-11:00am: Networking Break —
11:00-11:40am: Panel Session: Hosted by Caroline Gaynor, Partner, Lightstone Ventures (moderator)
11:40-12:30pm: Public, Private, and Patient Capital: Exploring Financing Alternatives
Hugh Laverty, Head of Scientific Operations, Innovative Health Initiative (IHI)
Joey Mason, Venture Partner, Claret Capital Partners
David O’Flynn, Director of Corporate Finance, Goodbody
Tyler Wanke, Wanke Family Office
David Filmore, Executive Editor, Market Pathways (moderator)
12:30-1:10pm: Does Scale Rule or Is Their Room for Mid-Sized Players?
Chris Eso, Global Head of Corporate and Business Development, M&A and Ventures, Medtronic
Virginia Giddings, Vice President of Exploration, Edwards Lifesciences
Jennifer Kozak, Vice President, Business Development, Johnson & Johnson MedTech
Mirren Mandalia, Vice President, Corporate Development & Venture, LivaNova
Rupert Winckler, Vice President Business Development, Olympus Corporation
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
1:10-2:20pm: Lunch (Saddle Room) Lobby Level
2:30-3:10pm: Is There Still a Place for a Medtech Public Market or is M&A the Only Game in Town?
Matt Gilbert, Managing Director, XMS Capital Partners
Mark Secrest, Managing Director and Co-Head of Healthcare Investment Banking, BTIG
Dan Wolf, Managing Director, Healthcare Investment Banking, Piper Sandler
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
3:10-3:15pm: Moderator —
3:15-3:55pm: Presenting companies
3:55-4:10pm: Networking Break — Great Room Foyer
4:10-4:50pm: Panel Session: Hosted by Roger Brooks, President & CEO, R Brooks Group
4:50-4:55pm: Moderator —
4:55-5:25pm: Presenting companies
5:30-6:15pm: Medtech By the Numbers:
Susana Amorim, Investment Manager - Healthtech Venture & Growth, Gilde Healthcare
Megan MacDonagh, Vice President, Medtech, Ally Bridge
Ruben Osnabrugge, Partner, 415 Capital
Jennifer McMahon, Partner, Seroba (moderator)
6:15-7:45pm: Networking Reception
Day 3 - Thursday, April 30, 2026
8:00-8:30am: Registration & Welcome Coffee —
8:30-9:10am: Smart Capital Strategies: Navigating Non‑Dilutive Funding in MedTech
Cepta Duffy, Manager Lifesciences, Enterprise Ireland (moderator)
9:15-9:55am: Can Corporate Venture Fill the Early-Stage Funding Gap?
Justin Castelli, Vice President, New Business Development, Boston Scientific
Gilad Glick, Vice President, Venture Investments, JJDC
Nathan Harrington, Managing Partner, Philips Ventures
Murielle Thinard McLane, Managing Partner and President, Intuitive Ventures
Dan Sheehan, Vice President, Venture Capital, Medtronic
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
10:00-10:05am: Moderator —
10:05-10:55am: Presenting companies
11:00-11:40am: Panel Session hosted by Sophie Hughes, Investment Analyst, Seroba (moderator)
11:40-11:45am: Moderator —
11:45-12:35pm: Presenting companies
12:35-1:10pm: Could This Be the Year Real MDR Change Begins?
Stephen Levin, Editor-in-Chief, Market Pathways (moderator)
1:10pm: Event concludes with working box lunch
